Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DUIA46
|
|||
| Drug Name |
SRP-9004
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Limb girdle muscular dystrophy [ICD-11: 8C70.4] | Phase 1/2 | [1] | |
| Company |
Sarepta Therapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sarcoglycan alpha (SGCA) | Target Info | Replacement | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Sarepta Therapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.